Science Library
Click the Titles Below to read this information on a 3rd party site.
Alternative Medicine Solution offers these links for informational purposes only and makes no claim as to the validity of the information hosted on these 3rd party websites.
German researchers have determined that epigallocatechin-3-gallate (EGCG)—a flavonoid found in green tea—inhibits the hepatitis C virus (HCV) from entering liver cells. Study findings available in the December issue of Hepatology, a journal published by Wiley-Blackwell on behalf of the American Association for the Study of Liver Diseases, suggest that EGCG may offer an antiviral strategy to prevent HCV reinfection following liver transplantation.
| from Jules: many studies in the past few years conducted by Peter Ferenci have shown IV silibin to have significant antiviral efficacy against HCV (see link below). |
Naringenin inhibits the assembly and long-term production of infectious hepatitis C virus particles through a PPAR-mediated mechanism.
Hepatitis C is an infectious disease of the liver that can cause miserable symptoms including fatigue, lack of appetite, abdominal pain, nausea and vomiting. Caused by a virus, hepatitis C affects about 200 million people worldwide. In the U.S. alone, one to two percent of the population is infected. Not only can this infectious disease cause scarring of the liver, cirrhosis, and eventually liver failure, but a significant number of people with hepatitis C also develop sometimes fatal liver disease or cancer.
Executive Summary
The Hepatitis C Trust held a web-based survey from April 2006 to September 2007 that asked about people’s experience of anti-viral hepatitis C treatment and in particular how they felt up to 3 years after finishing the treatment. 500 respondents completed the questionnaire.
Key findings:
A group of Australian scientists have been able to cure HIV-like infections in mice by boosting their immune systems.Doctor
Marc Pellegrini from Melbourne's Walter and Eliza Hall Institute found a
hormone known as Interleukin 7 stimulates the body's response to an
infection, causing it to clear the virus.This process is called immune exhaustion."We
found that Interleukin 7 boosted the immune response in a pretty
profound fashion, such that animals were able to gradually clear the
virus without too much collateral tissue damage," Dr Pellegrini said.
Hepatitis C virus (HCV) can breach the blood-brain barrier
and infect support cells in the brain, triggering inflammatory
changes that ultimately result in damage to neurons,
suggests new research published in the open access online
journal PLoS One. Findings from this autopsy
study may help explain how HCV infection causes neurocognitive
There’s truly only one way to ensure that every ingredient in every bottle of Pure Synergy will meet the uncompromising quality standards of Mitchell May – and that’s to make Pure Synergy ourselves, in our award winning facilities. The extraordinary quality of Pure Synergy begins with the cultivation of our very specialized ingredients and continues through every stage of processing, packaging and shipping.
Eating dark chocolate reduces damage to the blood vessels of cirrhotic patients and also lowers blood pressure in the liver, according to research presented this week at the International Liver Congress in Vienna.
http://www.canada.com/health/story.html?id=2910443
http://hubpages.com/hub/Valentines_Day_and_Chocolate
http://www.nutraingredients-usa.com/Research/Dark-chocolate-could-be-beneficial-to-liver-patients
The Spanish research suggests dark chocolate is helpful in lowering blood pressure in the liver and also limits blood vessel damage in the area for patients with cirrhosis.
"This study shows a clear association between eating dark chocolate and portal hypertension and demonstrates the potential importance of improvements in the management of cirrhotic patients, to minimize the onset and impact of end stage liver disease and its associated mortality risks," Mark Thursz, vice-secretary of the European Association for the Study of Liver, said in a news release.
Note: These statements have not been evaluated by the FDA.
The product is not intended to diagnose, treat, cure, or prevent any disease.

